West Pharmaceutical Services Inc (WST)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: FABRICATED RUBBER PRODUCTS, NEC

530 HERMAN O. WEST DRIVE EXTON, PA 19341

West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. Its business operations are organized into two segments: Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its products include stoppers and seals for vials, prefillable syringe components and systems, components for intravenous and blood collection systems, safety and administration systems, advanced injection systems, and contract design and manufacturing services. Its customers include the producers and distributors of pharmaceuticals, biologics, medical devices and personal care products.

Data based on most recent fiscal year report
Market Cap6.242 Billion Shares Outstanding74.25 Million Avg Volume577.351 Thousand
1-Yr BETA vs S&P TR0.923 Current Ratio2.66 Quick Ratio1.89
View SEC Filings from WST instead.
Q3 2019 All Institutions Hedge Funds 1
To trade WST now:
Filers who had this stock in their top 10: 5 2 (0.21%)
13F Filers holding this stock: 393 50 (5.22%)
Aggregate 13F shares on 09/30/2019: 66.453 Million 6.495 Million
Aggregate 13F shares on 06/30/2019: 67.179 Million 6.625 Million
Percent change: -1.08% -1.96%
Funds creating new positions: 62 14
Funds Adding to an existing position: 135 20
Funds closing out their position: 31 4
Funds reducing their position: 133 13
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding WST (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JOHNSON PAULA A

  • Director
0 2019-11-15 1

WEILAND JOHN H

  • Director
4,090 2019-11-12 0

FAVORITE ANNETTE F SR. VP HUMAN RESOURCES OFFICER

6,913 2019-10-07 3

BUTHMAN MARK A

27,277 2019-09-30 4

ZENNER PATRICK J

  • Director
122,216 2019-09-24 1

PUCCI PAOLO CHIEF EXECUTIVE OFFICER

  • Officer
707,417 2019-09-11 1

MICHELS DOUGLAS A

  • Director
0 2019-08-22 2

MOREL DONALD E JR

  • Director
50,125 2019-08-22 0

BRITELL JENNE K

  • Director
105,878 2019-08-19 0

BIRKETT BERNARD SR VP, CFO & TREASURER

9,583 2019-06-21 3

YOUNG ROBERT C

  • Director
0 2019-06-12 0

FEDERICI WILLIAM J

  • Director
0 2019-06-11 0

WELTERS ANTHONY

  • Director
0 2019-05-14 0

FLYNN KAREN

  • Director
28,212 2019-05-09 1

FEEHERY WILLIAM F

22,236 2019-05-07 1

HOFMANN THOMAS W

39,816 2019-05-07 1

LAI GOLDMAN MYLA

12,943 2019-05-07 1

KELLER DEBORAH L

4,881 2019-05-07 2

MALONE DANIEL VICE PRESIDENT & CONTROLLER

29,020 2019-04-30 2

MILLER GEORGE LLOYD SR. VP, GC & CORP. SEC.

17,926 2019-03-01 2

MONTECALVO DAVID A SVP, GLOB OPS AND SUPPLY CHAIN

3,148 2019-03-01 2

ABRAHAM SILJI CHIEF DIGITAL & TRANS OFFICER

4,642 2019-03-01 3

GREEN ERIC MARK PRESIDENT & CEO

69,031 2019-02-19 1

LAI QUINTIN J VP CORP DEVELOPMENT & STRATEGY

1,221 2019-02-19 1

NEAFSEY JOHN P

  • Director
167,088 2019-01-09 0

ANDERSON MICHAEL A VICE PRESIDENT & TREASURER

  • Officer
63,784 2016-03-01 0

LENNARTZ HEINO PRESIDENT EUROPE

  • Officer
12,624 2016-02-25 0

PAPROSKI JOHN E PRESIDENT-DELIVERY SYSTEMS

  • Officer
103,960 2016-02-23 0

BEDWELL WARWICK PRESIDENT, PHARMA PKGS SYSTEMS

  • Officer
38,778 2016-02-23 0

RYAN CHRISTOPHER G PRESIDENT, PPS, AMERICAS

  • Officer
684 2016-02-23 0

LUZZI RICHARD D SR. VP, HUMAN RESOURCES

  • Officer
100,938 2015-02-27 0

GAILEY JOHN R SR. VP, GEN. COUNSEL & SEC.

  • Officer
75,588 2015-02-17 0

HUNT JEFFREY C VP PHARMA PCKG SYSTEMS

  • Officer
0 2014-02-24 0

BUSHEY RACHAEL M VP, DEPUTY GEN COUN & CORP SEC

  • Officer
0 2014-02-24 0

JOHNSON L ROBERT

  • Director
19,437 2013-08-22 0

MCMILLAN DONALD A PRESIDENT PHARMA SYSTEMS NA

  • Officer
15,007 2012-02-21 0

WORDEN GEOFFREY F

  • Director
19,082 2011-05-03 0

ABBOTT JOSEPH E CORPORATE CONTROLLER

  • Officer
21,525 2011-02-25 0

ELLERS STEVEN A COO & PRESIDENT

  • Officer
180,457 2011-02-22 0

VAN DIJK RONALD PRESIDENT ASIA PACIFIC

  • Officer
7,527 2010-05-04 0

MULLARKEY MATTHEW T CHIEF OPERATING OFFICER

  • Officer
620 2009-12-11 0

HARGESHEIMER ROBERT S PRESIDENT-THE TECH GROUP

  • Officer
17,918 2009-08-26 0

KEATING ROBERT J PRES. EUROPE & ASIA PACIFIC

  • Officer
28,037 2009-02-24 0

FILHO FABIO DE SAMPAIO DORIA PRES., EUROPE & ASIA PACIFIC

  • Officer
0 2009-02-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FAVORITE ANNETTE F SR. VP HUMAN RESOURCES OFFICER

2019-10-07 F 1,355 $141.59 d 6,913 6,912.96 direct

BUTHMAN MARK A

2019-09-30 A 159 $141.82 a 10,485 27,276.89 direct
Click here to report any possible errors with this stock listing.

Elevate your investments